Deviated Septum Treatment — Cost, Top Hospitals & Success Rates | MyMedicPlus

A deviated nasal septum is a displacement of the nasal septum — the cartilage and bone wall dividing the nasal cavity into two passages — away from the midline, causing unequal airflow through the nostrils. It is one of the most common anatomical variations, present to some degree in up to 80% of the population, though only a minority produce clinically significant obstruction requiring treatment. The deviation may be congenital (present from birth) or acquired following nasal trauma.

Symptoms of a clinically significant deviated septum include unilateral or bilateral nasal obstruction that worsens with upper respiratory infections, nasal congestion affecting sleep quality, snoring, sleep-disordered breathing, recurrent sinusitis due to impaired mucociliary clearance and sinus drainage, epistaxis (nosebleeds) from dried mucosa over the nasal spur, headaches, and reduced sense of smell. The condition is diagnosed by anterior rhinoscopy and nasal endoscopy by an ENT specialist.

Treatment is guided by symptom severity and the degree of functional impairment. Medical management with intranasal corticosteroid sprays, antihistamines, and nasal decongestants addresses the inflammatory mucosal component but does not correct the underlying structural deviation. Definitive treatment is surgical: septoplasty — the surgical correction of the deviated septum — is among the most commonly performed ENT procedures worldwide, often combined with turbinate reduction (to address compensatory turbinate hypertrophy on the wider nasal side) for optimal airway improvement.

Septoplasty directly treats symptomatic nasal obstruction caused by septal deviation, including C-shaped deviations, S-shaped deviations, septal spurs (bony projections), and caudal septal deviations near the nasal tip that cause external nasal valve collapse. Chronic rhinosinusitis attributed to impaired sinus drainage secondary to a narrow nasal cavity from septal deviation is frequently addressed with concurrent functional endoscopic sinus surgery (FESS).

Recurrent anterior epistaxis from a prominent septal spur, where the sharp edge tears the overlying mucosa during nose blowing or air drying, is another specific indication. Obstructive sleep apnoea with a significant nasal component — where nasal obstruction forces mouth breathing that destabilises the upper airway during sleep — may benefit from septoplasty as part of a combined surgical approach. Difficulty tolerating CPAP therapy for obstructive sleep apnoea due to high nasal resistance is an important functional indication: septoplasty significantly improves CPAP mask tolerance by reducing the pressure needed to deliver therapeutic airflow. In children, a traumatic septal deviation causing significant asymmetric nasal obstruction may be addressed, though surgeons typically defer definitive septoplasty until nasal growth is complete at 16–18 years.

The ideal candidate for septoplasty is an adult patient aged 18 or older who has experienced clinically significant nasal obstruction for more than three months that has not responded adequately to a three-month trial of medical management (intranasal corticosteroids, antihistamines for allergy component). Nasal endoscopy should confirm that the septum is the primary anatomical cause of obstruction — distinguishing it from turbinate hypertrophy alone, nasal polyps, or inferior turbinate enlargement from allergic rhinitis, all of which require different interventions. A CT scan of the sinuses and skull base is useful preoperatively to map septal anatomy, assess for concurrent sinus disease, and plan turbinate surgery.

Contraindications include active nasal infection or acute sinusitis (surgery should be deferred until the infection is resolved), bleeding disorders or anticoagulant therapy requiring perioperative management, pregnancy, and significant uncontrolled medical comorbidities. Patients with body dysmorphic disorder seeking cosmetic improvement in the absence of functional symptoms require psychological assessment rather than surgical intervention. Children under 16–18 are generally not offered septoplasty due to ongoing nasal growth; a limited caudal septoplasty may be performed in selected cases of severe congenital obstruction. Patients with concurrent allergic rhinitis must have their allergy optimally controlled before and after surgery, as ongoing mucosal inflammation reduces the surgical benefit.

Standard endoscopic septoplasty is performed endonasally under direct visualisation with a 0-degree nasal endoscope. A hemitransfixion or Killian incision is made on the concave side of the nasal septum, and the mucoperichondrial flap is elevated to expose the deviated cartilage and bone. The deviated component is selectively resected, scored, or straightened, preserving at least 15 mm of the dorsal and caudal septal strut to maintain nasal support. Bony spurs are removed using a chisel or powered microdebrider. The mucoperichondrial flaps are repositioned and secured.

Submucous resection (SMR) is the traditional open technique where more aggressive removal of deviated cartilage is performed; it carries a higher risk of saddle nose deformity and is less favoured than the more conservative endoscopic septoplasty. Extracorporeal septoplasty involves complete removal, reshaping, and reimplantation of the deviated cartilage, used for severe dislocated septal deviations and caudal dislocations. Septorhinoplasty combines functional septoplasty with cosmetic external rhinoplasty to simultaneously address the external nasal appearance and internal airway obstruction — this is appropriate when the patient has both functional and aesthetic concerns.

Inferior turbinate reduction is typically performed concurrently with septoplasty in patients with compensatory turbinate hypertrophy. Techniques include submucosal diathermy, radiofrequency ablation (Coblation), powered microdebrider turbinoplasty, and partial turbinectomy, each offering different balances of efficacy and risk of atrophic rhinitis. Concurrent FESS is performed when significant paranasal sinus disease is identified preoperatively, maximising the functional outcome of the combined procedure.

Published outcome data for septoplasty demonstrate that 75–85% of patients report significant improvement in nasal airflow and satisfaction with breathing at 12 months post-surgery. Acoustic rhinometry and peak nasal inspiratory flow studies confirm objective nasal airway improvement in the majority of cases. Patients report reductions in snoring, improved sleep quality, and reduced frequency of sinusitis episodes. In patients with concurrent allergic rhinitis, the combination of turbinate reduction and septoplasty plus ongoing medical management for allergy achieves superior nasal airflow outcomes compared to either intervention alone.

Patients who undergo septoplasty to improve CPAP tolerance demonstrate measurable reductions in CPAP pressure requirements and significant improvements in CPAP adherence scores at six months. For patients with recurrent epistaxis from a septal spur, removal of the spur provides definitive control of nosebleeds in approximately 85% of cases. Quality of life measures including the Sinonasal Outcome Test-22 (SNOT-22) consistently show significant improvements following septoplasty, with the most pronounced benefits in the areas of nasal function, sleep quality, and overall health wellbeing.

Septoplasty is a safe procedure with a complication rate of approximately 1–5%. Primary haemorrhage during surgery is managed intraoperatively; secondary postoperative bleeding requiring intervention occurs in approximately 1–3% of cases. Septal haematoma — accumulation of blood between the mucoperichondrial flaps — can occur within 24–48 hours of surgery if bilateral flaps are not properly reapposed; it presents as sudden increased nasal obstruction and is managed by immediate drainage to prevent cartilage necrosis and saddle nose deformity. Septal perforation — a through-and-through hole in the septum — is the most significant long-term complication, occurring in 1–2% of cases, typically small and asymptomatic, but can cause crusting, epistaxis, and a whistling sound; large perforations rarely require repair with mucosal flaps or prosthetic buttons.

Saddle nose deformity from excessive dorsal cartilage resection is preventable by adhering to the principle of preserving adequate L-strut support. Nasal bridge asymmetry, alar collapse, and external nasal tip changes are uncommon but possible, particularly with aggressive resection or concurrent rhinoplasty. Reduced sense of smell (hyposmia) is transient in most cases, resolving as mucosal oedema subsides, but rarely can be permanent. Persistence or recurrence of nasal obstruction after septoplasty may indicate residual septal deviation, progressive turbinate hypertrophy, or developing nasal valve stenosis, requiring reassessment.

Nasal splints or internal silicone sheets are often placed at the end of surgery to support the septum during healing and prevent haematoma; these are removed at five to seven days postoperatively in the clinic. Nasal packing, if used, is removed at 24–48 hours — modern haemostatic materials and biodegradable splints have largely replaced traditional packing, significantly improving patient comfort in the postoperative period. Patients typically return home on the day of surgery or after one overnight admission.

Expected postoperative symptoms include nasal congestion and crusting for two to four weeks as the mucosal lining heals. Saline nasal irrigation (e.g., NeilMed, Sterimar) twice daily from day two post-operatively is strongly recommended to clear blood clots and surgical debris, reduce crusting, and accelerate mucosal healing. Full nasal breathing improvement is typically noticed from two to six weeks as postoperative swelling resolves. Patients are advised to avoid strenuous exercise for two weeks, nose blowing for one week, and contact sports for six weeks. Follow-up is scheduled at one week for splint removal and wound check, at six weeks for assessment of nasal airway and turbinate healing, and at three to six months for final outcome assessment with nasal endoscopy.

Septoplasty in the United States as a day surgical procedure costs $5,000–$12,000 without insurance (including surgeon, anaesthesia, and facility fees), depending on whether turbinate reduction or concurrent sinus surgery is performed. Insurance coverage requires documented functional impairment — purely cosmetic septoplasty is not covered. In the UK, septoplasty on the NHS is available for functional cases with waiting times up to 18 months; private septoplasty in the UK costs £3,000–£6,000. Concurrent rhinoplasty significantly adds to cost as it incorporates a cosmetic component.

Medical tourism offers significant savings for patients requiring septoplasty with or without rhinoplasty. In India, functional septoplasty with turbinate reduction at accredited ENT centres costs $1,500–$3,000. Combined septorhinoplasty (functional septoplasty plus cosmetic rhinoplasty) costs $3,000–$6,000 — compared to $10,000–$20,000 in the US. Thailand (Bumrungrad, Bangkok Hospital), Turkey (accredited rhinoplasty centres in Istanbul and Ankara), and South Korea offer comparable combined septorhinoplasty at 40–65% lower cost. Recovery in-country of two weeks is recommended before long-haul air travel to minimise bleeding risk and allow initial healing.

Medical management with intranasal corticosteroid sprays (mometasone, fluticasone, budesonide) used regularly for three months can reduce mucosal inflammation, shrink turbinate tissue, and modestly improve nasal airflow in mild-to-moderate deviated septum cases, particularly when allergic rhinitis is a coexisting contributor. Combination therapy with antihistamines and decongestants provides additional temporary relief. However, these therapies do not correct the underlying structural deviation and their benefit is limited and non-permanent.

For patients who are not surgical candidates or decline surgery, nasal dilator strips (Breathe Right) applied externally over the nasal valve area and internal nasal dilators improve external valve patency and may help patients with significant nasal valve collapse. For septoplasty candidates who wish to also address nasal tip or bridge appearance, injectable rhinoplasty with hyaluronic acid filler is a non-surgical alternative that can improve nasal symmetry and dorsal irregularities without addressing the internal septum; this is appropriate only for selected cosmetic concerns and has no effect on airway function. External nasal valve support devices used during CPAP therapy can substitute for septoplasty in some patients requiring CPAP for sleep apnoea.